Iqvia Holdings Inc (IQV)

261.68
-1.05(-0.40%)
After Hours
261.68
0.00(0.00%)
- Real-time Data
  • Volume:
    833,627
  • Bid/Ask:
    247.00/290.00
  • Day's Range:
    258.33 - 266.50

IQV Overview

Prev. Close
262.73
Day's Range
258.33-266.5
Revenue
13.54B
Open
265.11
52 wk Range
165.52-272.25
EPS
3.93
Volume
833,627
Market Cap
49.99B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
756,957
P/E Ratio
66.56
Beta
1.4
1-Year Change
53.38%
Shares Outstanding
191,039,501
Next Earnings Date
Feb 16, 2022
What is your sentiment on Iqvia Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Iqvia Holdings Inc Company Profile

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralBuyStrong Buy
Technical IndicatorsBuySellSellSellStrong Buy
SummaryStrong BuyNeutralNeutralNeutralStrong Buy
  • SYHN
    0
    • Keeps dropping, keep buying :)
      0
      • impressive run from June 2018
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.